Erenumab for preventing migraine

12th April 2021 by Dr Louise Hudman

Erenumab for preventing migraine

This is a new guideline from NICE advising that erenumab can be used for the prevention of migraine, published in March.

I did a blog a couple of months ago on galcanezumab, which was recently approved by NICE for the prevention of migraine, and erenumab has been approved for the same circumstances as galcanezumab.

It comes in two strengths: only the 140mg dose has been approved, as the 70mg dose wasn’t effective enough.

Is erenumab any more effective than galcanezumab?

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

Related content

"I have been a member of the NASGP for the past nine years and have found the advice and support offered invaluable. NASGP passionately champion for safe and fair working conditions for locums, which is crucial in an age of increasing medical litigation.

LocumDeck is a must for every locum who just wants to get on with the job that they were trained to do."

Dr Fiona Munro

Dr Fiona Munro

See the full list of features within our NASGP membership plans

Membership